Lombard Odier Asset Management Europe Ltd Sells 29,000 Shares of Waystar Holding Corp. $WAY

Lombard Odier Asset Management Europe Ltd decreased its holdings in Waystar Holding Corp. (NASDAQ:WAY) by 42.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 40,000 shares of the company’s stock after selling 29,000 shares during the period. Lombard Odier Asset Management Europe Ltd’s holdings in Waystar were worth $964,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in WAY. Advent International L.P. purchased a new position in Waystar in the 4th quarter worth approximately $362,212,000. Alliancebernstein L.P. raised its position in shares of Waystar by 3,883.4% during the second quarter. Alliancebernstein L.P. now owns 3,268,932 shares of the company’s stock valued at $133,601,000 after buying an additional 3,186,869 shares during the last quarter. Alyeska Investment Group L.P. lifted its holdings in shares of Waystar by 4,717.4% in the third quarter. Alyeska Investment Group L.P. now owns 1,814,648 shares of the company’s stock worth $68,811,000 after buying an additional 1,776,979 shares in the last quarter. Bamco Inc. NY purchased a new position in shares of Waystar in the fourth quarter worth $45,642,000. Finally, Norges Bank bought a new position in shares of Waystar during the fourth quarter worth $44,627,000.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on WAY. Weiss Ratings downgraded shares of Waystar from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. Barclays dropped their price objective on shares of Waystar from $36.00 to $25.00 and set an “overweight” rating for the company in a report on Wednesday, May 20th. JPMorgan Chase & Co. cut their price objective on Waystar from $40.00 to $38.00 and set an “overweight” rating for the company in a research report on Thursday, April 30th. Morgan Stanley started coverage on Waystar in a report on Monday, March 30th. They issued an “equal weight” rating and a $28.00 target price on the stock. Finally, UBS Group set a $34.00 target price on Waystar in a research report on Monday, July 20th. Three investment analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $35.23.

Waystar Price Performance

Shares of NASDAQ WAY opened at $22.51 on Monday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.37. Waystar Holding Corp. has a 12-month low of $17.26 and a 12-month high of $41.47. The firm’s 50-day moving average price is $20.45 and its 200-day moving average price is $23.51. The stock has a market capitalization of $4.32 billion, a price-to-earnings ratio of 33.60, a P/E/G ratio of 0.89 and a beta of 0.08.

Waystar (NASDAQ:WAY) last released its earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.03. Waystar had a return on equity of 6.99% and a net margin of 10.90%.The firm had revenue of $313.87 million for the quarter, compared to the consensus estimate of $311.74 million. During the same quarter in the previous year, the company posted $0.32 EPS. The company’s revenue for the quarter was up 22.4% compared to the same quarter last year. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. On average, equities research analysts anticipate that Waystar Holding Corp. will post 1.46 EPS for the current fiscal year.

Waystar Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.